使用Nucleus®人工耳蜗的成人大型队列植入后24个月内电刺激水平的变化
研究分析680例使用Nucleus植入体的成人植入后2至24个月共7个时间点的T值、C值和动态范围。结果显示T值在3个月后、C值在6个月后趋于稳定,但个体间变化程度不一,约65%至75%的参与者在3至6个月比较中变化≤20%动态范围。
要点
- T值在3个月后、C值在6个月后趋于稳定。
- 3至6个月比较中约65%至75%参与者变化≤20%动态范围。
- 耳硬化症组和语前聋组的水平变化程度显著更大。
核心结论
- 植入后3个月和6个月后,平均T值和C值分别趋于一致,但个体间变化程度不一。
- 对于耳硬化症、语前聋起病以及植入3个月后水平变化超过20%动态范围的患者,结果强烈支持在植入后24个月内频繁监测电刺激水平。
研究设计与样本
- 回顾性分析680例使用Nucleus植入体的成人,提取植入后2、3、6、9、12、18、24个月共7个时间点的T值、C值和动态范围。
- 对四个耳蜗分段计算每个时间点的平均水平,并对连续6个时间点比较分析各水平的变化程度,可接受变化标准为≤20%动态范围。
主要发现
- 2个月时间点的平均T值显著低于3个月之后所有时间点。
- 2个月和3个月时间点的平均C值显著低于所有其他时间点。
- 顶段平均T值显著低于所有其他分段,下基底段平均T值显著低于上基底段。
- 平均C值在四个分段间均存在显著差异;基底段平均C值在周蜗轴阵列比直阵列高4个CL。
- 连续时间点比较的平均变化程度无显著差异;3至6个月比较中,所有分段约65%至75%的参与者显示平均可接受变化程度。
关键数值与推荐
- 可接受变化程度的标准为≤20%动态范围。
- 基底段平均T值变化程度显著大于所有其他分段。
- 耳硬化症组的平均水平变化程度显著大于所有其他组,语前聋起病组显著大于语后聋组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine electrical stimulation data over 24 months postimplantation in adult implant users. The first aim was to calculate mean T and C levels for seven time points, for four cochlear segments, and two array types. The second aim was to (a) analyze the degree of change in each of the T and C levels as a function of dynamic range for six consecutive time point comparisons, for the four segments, and (b) to determine the proportion of participants with an acceptable degree of change. The third aim was to examine relationships between demographic factors and degree of change. DESIGN: T levels, C levels, and dynamic ranges were extracted for 680 adults using Nucleus implants for the following postimplant time points: 2-, 3-, 6-, 9-, 12-, 18-, and 24-month. For each time point, mean levels were calculated for the four segments. The degree of change in each of the levels was analyzed for six consecutive time point comparisons. The criterion for an acceptable degree of change was ≤20% of DR. RESULTS: Mean T level was significantly lower for the 2-month time point compared with all time points after the 3-month time point. Mean C level was significantly lower for the 2- and 3-month time points compared with all other time points. Mean T level was significantly lower for the apical compared with all other segments and for the lower-basal compared with the upper-basal segment. Mean C level was significantly different across all four segments. Mean C level for the basal segments was 4 CLs higher for the perimodiolar array compared with the straight array. No significant differences were evident for the mean degree of change between consecutive time point comparisons. For all segments, approximately 65 to 75% of the participants showed an average acceptable degree of change in levels from the 3- to 6-month comparison. The mean degree of change in T levels was significantly greater for the basal segments compared with all other segments. The mean degree of change in levels was significantly greater for the otosclerosis group compared with all other groups, and for the prelingual onset of deafness group compared with the postlingual group. CONCLUSION: Given the very large cohort, this study provides evidence for the mean levels and the degree of change in these levels that should be expected for four segments in the first 24 months postimplantation for adults using Nucleus implants. The mean T and C levels were consistent after the 3- and 6-month time points postimplant, respectively. The degree of change was variable between individuals. For each segment, however, a large percentage of participants showed an average change of ≤20% in each of the T and C levels from the 3- to 6-month comparison. Given the large degree of change in levels for some groups, the results provide strong evidence in favor of frequent monitoring of levels in the first 24 months postimplantation for patients with otosclerosis, prelingual onset of deafness, and those who exhibit >20% change in levels after 3 months postimplantation.
引用
- Gajadeera EA, Galvin KL, Dowell RC, et al. The Change in Electrical Stimulation Levels During 24 Months Postimplantation for a Large Cohort of Adults Using the Nucleus® Cochlear Implant. Ear Hear. 2017. PMID: 28166089. doi:10.1097/AUD.0000000000000405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。